Company name Meeting status Company status

Daiichi Sankyo Co., Ltd. Requested SPONSOR

Sanofi Requested SPONSOR
Alfasigma Declined
BioNTech Requested
Hypera Pharma - Business Forum Requested
Shionogi & Co., Ltd. Requested MEMBER
FUJIFILM - Exhibitor Requested
Grifols Engineering SA - Business Forum
Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing
Requested
Business SPONSOR
Biolab Sanus Farmaceutica Requested
Kyoto University
Evotec Declined
Otsuka Pharmaceutical Co., Ltd. Requested SPONSOR
Mitsubishi Tanabe Pharma Corporation Requested
Taisho Pharmaceutical Co., Ltd. Declined
Aché Laboratórios Farmacêuticos S.A. - Business Forum Declined
Yokogawa Electric Corporation
Acino Requested
Blau Farmacêutica
Pierre Fabre SA Declined
NITTO DENKO CORPORATION Declined
FIOCRUZ/Bio-Manguinhos
Fuji Pharma Co. Ltd. Requested
Laboratorios Farmaceuticos Rovi Requested
Kaken Pharmaceutical Co., Ltd. Declined
Fresenius Kabi Requested
Boehringer Ingelheim Human Pharma Requested SPONSOR
Hikma Pharmaceuticals Requested
Extrovis AG
Novartis Requested SPONSOR
Clinigen Declined
Meiji Seika Pharma Co., Ltd.
Western University
Eurofarma Laboratórios SA Requested
University Health Network
Kyorin Pharmaceutical Co, Ltd Declined
FUJIFILM Pharmaceutical Division Declined
JT Pharma Requested MEMBER
Neuraxpharm Requested
Asahi Kasei Pharma Corporation Requested PRESENTING COMPANY
CureVac SE
Mochida Pharmaceutical Co., Ltd. Requested
Insud Pharma Requested
University of Bath
University of Calgary ACADEMIC CAMPUS
Hypera Pharma - Exhibitor Requested
Ferrer Internacional, S.A. Requested
Nippon Kayaku Co., Ltd. Requested
STADA Requested
Aché - Exhibitor Requested
ALVOGEN Declined
Zeria Pharmaceutical Co, Ltd Requested
Apotex Corporation Declined
Novartis - Exhibitor Requested SPONSOR
Zambon Group SPA Requested PRESENTING COMPANY
Accord Healthcare Requested
Teuto Laboratories Requested
Cristália Requested
Fiocruz - Fundação Oswaldo Cruz
Tokyo Medical And Dental University
GlobalData - Exhibitor
Menarini Group Requested
Ajinomoto Co., Inc. Requested
Chiesi Farmaceutici SpA Requested BIO BOARD
EMS
Teijin Limited Requested
University of Dundee
Apsen Pharmaceuticals Requested
Instituto Butantan
Glenmark Pharmaceuticals MEMBER
Hisamitsu Pharmaceutical Co., Inc. Requested
BIOCODEX Inc. Declined
Nissan Chemical Corporation
Almirall S.A Declined
LIBBS
National Research Council Canada
CMIC Group
Innovent Biologics, Inc. Declined
Apeloa Pharmaceutical Co.
Teijin Pharma Limited Requested
Olon SpA
Sumitomo Pharma Co.,Ltd Requested
AGC Inc.
CMIC Holdings Co., Ltd.
DKSH Requested
Chugai Pharmaceutical Co., Ltd PRESENTING COMPANY
Greater Paris University Hospitals/APHP
Biolab Farmacêutica Requested
Kowa Company, Ltd. Requested MEMBER
Orion Corporation Requested
Kyowa Kirin
Aristo Pharma GmbH Declined
STALLERGENES GREER Requested
THEA OPEN INNOVATION
Alfresa Holdings Corportion Declined
Clarivate
Servier Declined SPONSOR
Pharmascience
Japan Blood Products Organization
GSK Requested BIO BOARD
Senju Pharmaceuticals Co. Ltd
Taiho Pharmaceutical Co., Ltd. Requested
Italfarmaco Group
UKRI - STFC
National Institute for Health Research (NIHR)
Maruho Co., Ltd. Requested
Recordati
Otsuka Pharmaceutical Factory Declined
Fuso Pharmaceutical Industries, Ltd.
Grifols Engineering SA - Exhibitor
KISSEI Pharmaceutical Co., Ltd. Declined
Bayshore Specialty Rx
Eisai Co., Ltd. Requested MEMBER
Sanofi's Vaccines Business SPONSOR
Laboratorio Reig Jofre, S.A.
Faes Farma S. A. Declined
Esteve Requested
KM Biologics Co., Ltd. Requested
UBE Corporation Declined
Grünenthal GmbH Declined
Grifols Requested
Ceva Animal Health Declined
Ipsen Declined
Intas Pharmaceuticals Scheduled
Ferring Pharmaceuticals Requested
Cancer Research Horizons MEMBER
Santen Pharmaceutical Co., Ltd. Declined
Toray Industries Requested
Apobiologix
VIRBAC SA
 Company type(s) Brief description

Biotech or pharma, therapeutic R&D Daiichi Sankyo is a global pharmaceutical company.

Biotech or pharma, therapeutic R&D SANOFI is an innovative global Healthcare company focused
Biotech or pharma, therapeutic R&D on
No human
servicehealth
providers meeting requests please!
Biotech or pharma, therapeutic R&D Alfasigma
BioNTech is is an international
a global, clinical fully
stageintegrated pharmaceutical
biopharmaceutical
Biotech or pharma, therapeutic R&D company
Hypera is that researches,
the largest develops, Brazilian
fully integrated and manufactures
Pharmaceutical
Biotech or pharma, therapeutic R&D Company with a strong focus in business innovation.
SHIONOGI is a research-driven Japanese pharmaceutical
Biotech or pharma, therapeutic R&D company
FUJIFILMwithoffersaffiliates
a widein the US,
range Europe,for
of support UK, China
drug and ,
discovery
CMO,
BiotechCRO
or pharma, therapeutic R&D leveraging its technological excellence.
Grifols Engineering specializes in the field of Together with our
Supplier,
Biotech orengineering
pharma, therapeutic R&D biopharmaceutical
Family-owned sinceengineering, working
its establishment closelyBoehringer
in 1885, with the client
CMO, CRO
Biotech or pharma, animal health Ingelheim is one of
Biolab, a leading top 20 pharmaceutical
company in Brazil, ranks companies,
top 10 nationally,
Institute, hospital research present
IAC in 7 of
, Office countries. It's aAdvancement
Institutional key player in and
LATAM Market,
Academic,
CMO, CROtech transfer Communications, was established
Evotec is a life science company with at Kyoto University
a unique businessto
Other R&D
Biotech servicestherapeutic R&D
or pharma, model
Otsukafocused on delivering
Pharmaceutical highly biopharmaceutical
is a global effective new therapeutics
Biotech or pharma, therapeutic R&D company
Mitsubishiwith
Tanabea mission
Pharma to create better (MTPC)
Corporation health worldwide.
is expandingAt
Biotech or pharma, therapeutic R&D its global
Taisho is operations and building
a leading Japanese for future growth
pharmaceutical with the
company and
Biotech or pharma, therapeutic R&D has two sustaining pillars, Consumer Health
Leading Brazilian pharmaceutical company seeking in- Care (CHC)
Supplier, engineering licensing
Yokogawa ofislate-stage innovative
looking forward assets
to the (new small
opportunity molecules
to talk with
Other products
Biotech or services
or pharma, therapeutic R&D you
Acino is a specialty biopharmaceutical company focused onto
about future bioprocess industry. It will be our pleasure
Biotech or pharma, therapeutic R&D the commercialization
Blau Farmaceutica is aofprivate
innovative
ownedand established
company, established
Biotech or pharma, therapeutic R&D in Sao Paulo, with subsidiaries all over LATAM.
Pierre Fabre is an independent fully-integrated health care
Biotech or pharma, therapeutic R&D group
Nitto’s headquartered in France
proprietary delivery withprovides
platform a global lipids
footprint.
and Our
Biotech or pharma, therapeutic R&D formulations
Responsible that enable organdevelopment
for technological and cellular delivery of RNA-of
and production
Other R&D
Biotech servicestherapeutic R&D
or pharma, vaccines, reagents,
Tokyo-listed biopharmaceuticals
specialty pharma, focuses on and advanced
women’s health,
Biotech or pharma, therapeutic R&D biosimilars, and acute medical care products. With operations
Risvan® is a monthly LAI for schizophrenia approved by the
Biotech or pharma, therapeutic R&D US
KakenFDAis and EMA. It hasJapanese
fully-integrated demonstrated
pharmaoutstanding
companyefficacy
founded
Biotech or pharma, therapeutic R&D in 1948. We helps improve the quality of life
Caring for the critically ill Patient in the Hospital for patients by
CMO,
BiotechCRO
or pharma, therapeutic R&D Fresenius
As Kabi employs
a world-leading, globalover 43,000 people
pharmaceutical worldwide.
company our In
Biotech or pharma, therapeutic R&D outstanding team creates value through innovation
Hikma helps put better health within reach every day for for our
Biotech or pharma, therapeutic R&D millions of people
The Extrovis Groupin is
more than 50 countries
headquartered around the world.
in Switzerland,
Biotech or pharma, therapeutic R&D operating worldwide with subsidiaries and affiliates in India,
Biotech or pharma, therapeutic R&D Clinigen (Clinigen Group) is a global pharmaceutical and
Biotech or pharma, therapeutic R&D services company
Meiji Seika Pharma,with a unique combination
a “Specialty and Genericof businesses
Academic, tech transfer Pharmaceuticals Company”,
Discover how Western excelsisindedicated to research,
pre-clinical
Biotech
Biotech or
or pharma,
pharma, therapeutic R&D
animal health neurodegenerative
Regional Pharma inpharma, alongside
Latin America pioneering
looking in
for innovative
Biotech orhospital
Institute, pharma, therapeutic R&D
research drugs in-licensing
University through broad
Health Network (UHN)range of flexible
is a globally deal
recognized
Academic, tech transfer
Biotech or pharma, therapeutic R&D academic
Kyorin is a research-based pharmaceutical companyscientific
research hospital known for its pioneering in Japan
Biotech or pharma, therapeutic R&D with commercial franchises in ENT/ Respiratory/ Urology/
We are seeking out-licensing and investment opportunities for
Biotech or pharma, therapeutic R&D our clinical stage
JT Pharma oncology
is dedicated pipeline,
to the FF-10502
discovery, (small and
development,
Biotech or pharma, therapeutic R&D sales of novel human
NEURAXPHARM, therapeutics
a European leaderin the areas of
in pharmaceutical
Biotech or pharma, therapeutic R&D products for Pharma
Asahi Kasei the CENTRAL NERVOUS
Corporation (AKP)SYSTEM
is an R&D-based
Medical device
Biotech or or technology
pharma, therapeutic R&D pharmaceutical company headquartered
***NO SERVICE PROVIDERS PLEASE*** in Global
Tokyo, Japan,
Biotech or pharma, therapeutic R&D biopharmaceutical company
Mochida Pharmaceutical developing
(Mochida) a new class of
is a Japanese
Diagnostics
Biotech or pharma, therapeutic R&D biopharmaceutical
Insud company
Pharma is a leading headquartered
pharma companyinwithTokyo.
more than
CMO, CRO 40 years of experience globally focused on development,
Medical device or technology The University of Bath is one of the leading research
Other R&D
Institute, services
hospital research intensive
UCalgary universities
researchersinare
thepartnering
UK. with
Other
Biotech or pharma,services
products or therapeutic R&D industry sponsors to turn knowledge into
Hypera Pharma is a leading company in Brazil, with
Biotech or pharma, therapeutic R&D distinguished
Privately-held capability in different
multinational specialtyareas of the efficiently
bio-pharma
Biotech or pharma, therapeutic R&D managing a comprehensive,
Nippon Kayaku Co., Ltd. is a end-to-end value chain
Japanese pharmaceutical
Biotech or pharma, therapeutic R&D company specializing in oncology and oncology-related fields.
Biotech or pharma, therapeutic R&D Aché is a leading Brazilian pharmaceutical company with a
Biotech or pharma, therapeutic R&D strong
Alvogencommercial presence
is an international in prescriptioncompany,
pharmaceutical medicinesfocused
and
Biotech or pharma, therapeutic R&D on developing,
Zeria manufacturing,
Pharmaceutical marketinghealthcare
is a Tokyo-based and distributing
company
Biotech or pharma, therapeutic R&D focused on the discovery, development and
Apotex Inc. is a Canadian-based global health marketing
company ofthat
Biotech or pharma, therapeutic R&D produces high-quality,
Novartis contract affordableoffers
manufacturing and complex medicinesset
a fully integrated forof
Biotech or pharma, therapeutic R&D Contract Manufacturing
Zambon Biotech, Services
the Centre in Mammalian,
of External InnovationMicrobial
of
Biotech or pharma, therapeutic R&D Zambon
With group of companies,
an extensive presence in leverages the commercial
North America, Europe, South
Biotech or pharma,
Biotech or pharma, animal health
therapeutic R&D America, Australia,
Laboratorio New Zealand,
Teuto Brasileiro is oneSouth
of theAfrica and
leading more
companies
Biotech or pharma, therapeutic R&D in the Brazilian
CRISTÁLIA is apharmaceutical market, boastingcompany,
private owned pharmaceutical a rich with
Institute, hospital research a broad is
Fiocruz footprint
one of across
the mosttherespected
main LATAM markets.
research, higherA leader
Academic, tech
Academic, tech transfer
transfer education
The Tokyoand publicand
Medical health institution
Dental in Latin
University America.
encourages
Medical device
IT, information or technology collaboration with companies around the world
GlobalData is a data and analytics company providing to translate
the Life
Supplier,
Biotech orengineering
pharma, therapeutic R&D Science Community with Market and Competitive
Multinational pharma company with the presence in multipleIntelligence
Biotech or pharma, animal health therapeutic
The Ajinomoto areas: oncology,
Group cardiometabolic,
is a global company focusedanti-infectives,
on the
Biotech or pharma,
Biotech or pharma, therapeutic
therapeutic R&D
R&D research,
Chiesi development,
Farmaceutici is a and
Globalmanufacture of highcompany,
Pharmaceutical quality
Biotech or pharma, therapeutic R&D headquartered in Parma, Italy, dedicated to the
EMS/NC Pharma is the #1 pharma organization in Brazil and research,
Biotech or pharma, therapeutic R&D top 10contribute
Teijin in Latam with an established
to value maximization footprint in Prescription,
of regenerative
CMO,
BiotechCRO
or pharma, therapeutic R&D medical products
The University by partnering
of Dundee for development
is internationally and for its
recognised
Institute,
Biotech orhospital
pharma,research
therapeutic R&D researchisexcellence
APSEN a Brazilianinpharmaceutical
drug discoverycompany,
and translational
focused on
Biotech or pharma, therapeutic R&D innovative drugs, interested in-licensing opportunities.
Instituto Butantan, founded in 1901 to support public health,
Academic, tech transfer
Biotech or pharma, therapeutic R&D produces
Glenmark vaccines for Influenza,
Pharmaceuticals Hepatitis,
is a global, Rabies,research-
integrated, DTaP,
Biotech or pharma, therapeutic R&D led pharmaceutical
Hisamitsu company
Pharmaceutical pursuing
Co., the discovery
Inc. is Japan based and
Biotech or pharma, therapeutic R&D pharmaceutical
Biocodex company with
is a family-owned full capability company
pharmaceutical of development
that
Biotech or pharma, therapeutic R&D provides innovative healthcare solutions to patients
Nissan Chemical is an oligonucleotide therapeutics discovery in more
Biotech or pharma, therapeutic R&D company
Almirall is developing multipleDermatology
a leading Medical pre-clinical programs
global including
Biotech or pharma, therapeutic R&D pharmaceutical
Libbs is a top 10company
Braziliandedicated to apply
pharmaceutical Science to
company
CMO, CRO
Biotech or pharma, therapeutic R&D specializing in the research
Canada's premier production of different dosage forms and
organization
Public, NPO, govt., therapeutic
Biotech or pharma, economic development
R&D CMIC offers end-to-end solutions for pharmaceutical
CMO, CRO
Biotech or pharma, therapeutic R&D companies, medicalisdevice
Innovent Biologics manufacturers
a leading and bio-ventures
biopharmaceutical company in
CMO, CRO China
Apeloadeveloping
is a leadingboth
CDMOinnovative and biosimilar
from China mAbs
and provides forstop
one
Other R&D
Biotech servicestherapeutic R&D
or pharma, solutions
Teijin from is
Pharma laba scale to GMP
subsidiary commercial
company supply
of Teijin for and a
Limited
Medical
CMO, CROdevice or technology fully integrated healthcare company responsible
Olon Group is a global leader in the development and for
Biotech or pharma,
Biotech or pharma, animal health
therapeutic R&D production
Sumitomo Pharmaof activeCo.,
pharmaceutical
Ltd., is a R&D ingredients (APIs) for
based pharmaceutical
CMO, CRO company
AGC Inc. and aims to provide
is a multinational innovative
corporation and effective
operating in 30+new
Investor or
Biotech (buy-side
pharma,ortherapeutic
sell-side research)
R&D countries,
CMIC offerswith $14 billionsolutions
end-to-end in revenue and $860 million in
for pharmaceutical
CMO,
BiotechCRO
or pharma, therapeutic R&D companies, medicala device
DKSH Healthcare, leadingmanufacturers and bio-ventures
market expansion service
Biotech or pharma, therapeutic R&D provider
Chugai, a member of Roche group, is a Japanesespecialists
to Asia, covering 14 markets with 8,000 company
Academic, tech transfer focused on creating innovative medicinal products which
Technology Transfer Office of AP-HP , the largest European
Institute,
Biotech orhospital
pharma,research
animal health University
Biolab is a Hospital System.
major pharma and prescription company in Brazil,
ranking among the top 10, with a presence in 7 countries and
Biotech or pharma, therapeutic R&D Global fully-integrated pharmaceutical company
Biotech or pharma, therapeutic R&D headquartered
Orion Corporationin Japan. Seeking mid-sized,
is a European, in-licensingpharmaceutical
opportunities
Biotech or pharma, therapeutic R&D company
Kyowa Kirinheadquartered
is Japan basedin Finland with a direct
fully integrated commercial
pharmaceutical
Biotech or pharma, therapeutic R&D company
Aristo is afrom drug discovery
pharmaceutical to marketing
company pharmaceutical
focussed in the
Biotech or pharma, therapeutic R&D commercialization
Stallergenes Greerand is apromotion of pharmaceutical
fully integrated global products
Biotech or pharma, therapeutic R&D biopharmaceutical company specialised in the diagnosis
Thea Open Innovation is part of Thea Group and is dedicated and
Investor (buy-side
Biotech or pharma,ortherapeutic
sell-side research)
R&D to partnering
Alfresa through in-licensing
is a Japan-based healthcare(+/-related
CoDevcorporate
or Equity group
CMO, CRO
Biotech or pharma, animal health and looking is
Clarivate™ fora IN-LICENSE
global leaderor in any other collaboration
providing solutions to
Digital
Biotechhealth
or pharma, therapeutic R&D accelerate the lifecycle of innovation
Servier is a €5.3bn independent pharmaceutical company
Biotech or pharma, therapeutic R&D headquartered
PharmascienceinInc. France with 22000privately
is a full-service employeesownedworldwide.
CMO,
BiotechCRO
or pharma, therapeutic R&D pharmaceutical
We are the No.1company with strong roots
plasma fractionation makerin in
Canada
Japan.and
We a
Biotech or pharma, therapeutic R&D discovered a novel
GSK is a fully virus
focused inactivated
biopharma plasma powder
company. with high
We prioritise
Biotech or pharma,
Biotech or pharma, animal health
therapeutic R&D innovation
Senju in vaccines and Japanese
is a research-based specialty medicines, maximising
pharmaceutical
Biotech or pharma, therapeutic R&D company
Taiho Pharmaceutical, a subsidiary of Otsuka Holdings Co.,a
that develops, manufactures and commercializes
Biotech or pharma, therapeutic R&D Ltd., is an R&D-driven
- In-licensing specialty
of late stage assetspharma focusing
for markets on in
mainly theEUtwoin
Other R&D services niche
STFC areas
is a United Kingdom government agency that conducts
Biotech orhospital
Institute, pharma, therapeutic R&D
research and fundsInstitute
National advanced research,
for Health andand
Careruns some of(NIHR)
Research the largest
is the
Public, NPO, govt., economic development
Biotech or pharma, therapeutic R&D Research arm of the NHS. We are funded by
Maruho Co., Ltd. is a leading pharmaceutical companythe UK's
Biotech or pharma, therapeutic R&D specializing in dermatology
No service providers meetingin requests
Japan. please (CRO, CMO or
Biotech or pharma, therapeutic R&D other
We are service
one ofproviders)
the main operating companies of Otsuka
Biotech or pharma, therapeutic R&D Holdings
Fuso Co., Ltd., with
Pharmaceutical conducting
Industries, Ltd.manufacture,
Established inR&D,
1937,sale,
Biotech or pharma, therapeutic R&D and started our business from the sale of
Grifols Engineering specializes in the field ofglucose. Today, we
Supplier,
Biotech orengineering
pharma, therapeutic R&D biopharmaceutical engineering,
Kissei is a R&D oriented Japaneseworking closely withcompany.
pharmaceutical the client
Biotech or pharma, therapeutic R&D We have clinical
Bayshore and pre-clinical
is a leading Canadian stage
healthassets seeking
services for for
provider a
Digital
Biotechhealth
or pharma, therapeutic R&D 3PL, wholesale,
Eisai Co, Ltd specialty pharmacy, nursing, home and clinic
Biotech or pharma, therapeutic R&D As a global pharmaceutical
Sanofi's vaccines business is company,
the GlobalweBusiness
are a fullyUnit of
Biotech or pharma, therapeutic R&D Sanofi
RJ hasresponsible for infectious
a strong portfolio disease vaccines.
in osteoarthritis, We are
musculoskeletal
Biotech - industrial
Biotech or pharma, &therapeutic
environmental
R&D pain
Faessegment
Farma S.A , dermatology and woman
1933, publicly health with
traded Spanish
Biotech or pharma, therapeutic R&D pharmaceutical
ESTEVE company,
is a leading with
private international scope
pharmaceutical , devoted
chemical group
Biotech or pharma, therapeutic R&D headquartered in Spain, with a widespread international
KM Biologics is a Japanese vaccine, blood-plasma products,
Biotech or pharma, therapeutic R&D recombinant proteins,
UBE corporation and discovery
is a drug veterinaryandvaccine manufacturer
chemical company
Biotech or pharma, therapeutic R&D focused on small molecule therapeutics and licensing
The Grünenthal Group is an independent, family-owned, them
Biotech or pharma, therapeutic R&D international
Grifols research-based
is a healthcare companypharmaceutical
committed tocompany
improvingwith
Investor
Biotech or(buy-side
pharma,oranimal
sell-side research)
health people’s health. Our more than 24,000 employees
Ceva Santé Animale is a fast growing, global animalin over 30
Biotech or pharma, therapeutic R&D healthcare company,
Ipsen is a global focused on thegroup
biopharmaceutical research, development
dedicated to
Biotech or pharma, animal health improving lives throughpharmaceutical
Intas is a multinational innovative medicines
companyin Oncology,
founded in
Biotech or pharma, therapeutic R&D 1976, dedicated
Ferring to the research,
is a research-driven, development,
specialty manufacture
biopharmaceutical
Academic, tech transfer committed to helping
Cancer Research people(CRH)
Horizons build healthy families and live
is a cancer-focused drug
Biotech or pharma,
Biotech or pharma, therapeutic
therapeutic R&D
R&D discovery, development and IP commercialisation
Santen is a global pharmaceutical company fully focused oncompany
Biotech - industrial & environmental the ophthalmic
Toray Group is fields, "eye diseases",
an Advanced Materialsincluding
Manufacturer
Biotech or
Biotech or pharma,
pharma, therapeutic
therapeutic R&D
R&D developing its
Apobiologix is business
a divisionin
of29 countries
Apotex Inc., and regions
Canada's leading
Biotech or pharma, animal health manufacturer of generic &laboratory
Worlwide pharmaceutical biosimilar dedicated
medicines.toOur focus is
Animal
Health
 Description

Daiichi Sankyo is dedicated to the creation and supply of

innovative
We are an pharmaceutical therapies
innovative global to improve
healthcare standards
company, driven byof
one purpose:
Alfasigma weItalian
is an chaseprivately-owned,
the miracles of science to improve
integrated
multinational
BioNTech is a global next generation immunotherapy the top
pharmaceutical company ranked among
company pioneering
Hypera Pharma, novelknown
formerly therapies for cancer andwas
as Hypermarcas, other
founded
SHIONOGI in 2001 and sinceonthen
concentrates the company
following has areas:
therapeutic
infectious diseases,
About FUJIFILM including vaccines, and diseases that
Corporation
FUJIFILM Corporation,
EXPERIENCE YOU CAN Tokyo,
COUNT Japan
ONis one of the major
Grifols Engineering
Boehringer Ingelheim specializes in the field of
Biopharmaceuticals GmbH is a leading
biopharmaceutical contract manufacturer — under the brand
Biolab is one of the largest Brazilian pharmaceutical
companies,
Kyoto rankingOffice
University's among Brazil's top 10
of Institutional pharmaceutical
Advancement and
Communications' (IAC) mission is to support
The Company leverages its multimodality platform forresearchers in
proprietary projects and believes
Otsuka Pharmaceutical within a network of partners
in maximizing valueincluding
through
alliances
Mitsubishi Tanabe Pharma Corporation (MTPC), which under
and partnerships. Aripiprazole, originally sold was
foundedisina 1678,
Taisho leadinghas its headquarters
Japanese in Doshomachi,
pharmaceutical companyOsaka,
and
has two sustaining pillars, Consumer Health Care
Privately-owned company founded 57 years ago, Aché is (OTC)
positioned
Yokogawa among
Electricthe largest pharmaceutical
Corporation is a Japanesecorporations
automation in
company, which has the number one market share in Japan
Blau is a leading Brazilian pharmaceutical company in the
institutional segment,
The Pierre Fabre Groupfounded in 1987
is a leading and a pioneer
independent in
French
healthcare group,iswith
Nitto BioPharma activities
a clinical ranging
stage from pharmaceuticals
biotechnology company
whose mission is to develop and deliver innovative,
The Institute of Technology on Immunobiologicals (Bio- life-
Manguinhos)
Fuji Pharma has is the unitenriching
been of the Oswaldo
the livesCruz Foundation
of women in Japan
since the early 1960s
Company Description: by developing innovative treatments for
ROVI
>Aboutis Kaken
a public pan-European company (ticker: ROVI) with a
Kaken (Tokyo
Fresenius KabiStock Exchange:
is a global 4521)company
healthcare is a specialty
that
specializes in
Boehringer lifesaving
Ingelheim is medicines and technologies
a world-leading, for
research-driven
biopharmaceutical company. Making new and better
We're a global company with a local presence across the
United
We areStates (US),tothe
dedicated theMiddle East and
development andNorth Africa (MENA)
manufacturing of
niche and differentiated finished-dose pharmaceutical
Novartis provides healthcare solutions that improve and
extend people’s
Clinigen lives.global
is a leading We use science-based
expert, innovation to
trusted by both
pharmaceutical and biotech companies, in accelerating
Meiji Seika Pharma is dedicated to research, development
and commercialization
At Western of innovative
University, ranked within and generic
the top 1% ofdrugs that
higher
education
Eurofarmainstitutions
is the lead worldwide, we are
Pharmaceutical pioneering
Company a new era
in Latin
America
UHN (top 10),
consists of 7being the unique
world-class Brazilian
research Company
institutes with
located
within the hospital system and include Princess
Kyorin Pharmaceutical Co., Ltd. headquarters in Margaret
Tokyo/Japan, KyorinCorporation
FUJIFILM Holdings employs 2300 staffs
brings and consolidated
cutting-edge solutions
to a broad range of global industries. Its proprietary
JT Pharma, the Pharmaceutical Division of Japan Tobacco core
(including Akros Pharma,
NEURAXPHARM US; Toriispecialty
is a PE-backed Pharmaceutical, Japan) is
pharmaceutical
company focused
AKP is a fully on CNS
integrated disorders. Our
pharmaceutical portfoliowith
company includes
capabilities
CureVac is ainglobal
R&D, manufacturing
biopharmaceuticaland company
commercialization.
in the field of
messenger
Mochida is actively seeking both in-licensing and out- 20
RNA (mRNA) technology, with more than
licensing
Insud opportunities
Pharma of pharmaceutical
is a 2,5 B€ development
vertically integrated pharma
company focusing both in innovative and generic drugs and
University of Bath: A world-class University in a World
Heritage
UCalgarycity.
researchers are partnering with industry sponsors
to turn knowledge
Hypera Pharma was intofounded in 2001 and through the years it
has consolidated
Ferrer its track
has a proven position as one
record of the leading
in bringing innovation in
pulmonary
Nippon Kayakuhypertension
Co., Ltd. with a strong focus
is a Japanese in EU and LatAm
pharmaceuticals and
functional
STADA is a German pharmaceutical company,annual
chemical materials company having focusing on
three pillars: generics, specialty pharma and non-prescription
Alvogen is the next generation pharmaceutical company.
Alvogen currently has is
Zeria Pharmaceutical commercial operations
a Tokyo-based around
healthcare the
company
focused
Apotex has an integrated portfolio of generic, biosimilarofand
on the discovery, development and marketing
innovative
NOVARTISbranded
contractpharmaceutical
manufacturing products
is a globalforcontract
global
manufacturing
Zambon Biotech player in of
is part thethe
biotech
Zambonfieldgroup
and cell & gene
of companies, it
is focused
With in growing
a robust product the portfolio
portfolio and pipeline
in growth of thespanning
segments, Zambon
Oncology,
RenownedCardiology,
for pioneeringNeurology, Nephrology,
the production Urology,
of generic
medications
CRISTÁLIA is in aBrazil,
privateTeuto
owned haspharmaceutical
solidified its position as a
company,
operating in the
Fiocruz runs moremain
thanLATAM markets.
a thousand As a leader
researchs and in
technological
Tokyo Medicaldevelopment projects, which
and Dental University produce
comprises the School of
Medicine and the School of Dentistry, where more
GlobalData serves over 4,000 world's largest companies than 800
with
over 600 healthcare analysts by gaining insights
MENARINI is a fully integrated privately owned pharma into
company with aGroup
The Ajinomoto long and
is asuccessful heritage
global company in strategic
focused on the
research,
The Chiesidevelopment,
Group currentlyandemploys
manufacture
~7,000of people
high quality
worldwide
and had a 2023 turnover of €3.03 billion.
EMS/NC Pharma is the #1 pharma organization in Brazil
according to IMS/IQVIA with global
Teijin is a technology-driven >USD1.5Bi
groupinoffering
gross sales
a wide
range
In the School of Life Sciences, we make fundamental as cell
of innovative solutions in the various fields such
discoveries
APSEN hason the molecular
been in the localand cellular
market mechanisms
since 1969. In these
five decades and more, APSEN has launched innvative
Instituto Butantan is a century-old Brazilian institution focused
on the description
Below research and development
is given of biological medicines for
in two parts:
1. Glenmark
Global HQ is inin Innovation
Saga, Japan, and Hisamitsu has a 100%-
owned subsidiary,
Biocodex Noven Pharmaceuticals,
is a family-owned pharmaceutical in Florida,that
company the
provides
About Us innovative healthcare solutions to patients in more
Nissan is
Almirall Chemical
a leading Corporation was founded incompany
global biopharmaceutical 1887 as Tokyo
focused on Medical
Libbs is seeking newDermatology.
opportunities to drive future growth
through
The licensing
National opportunities
Research Councilin NME,isvalue-added
(NRC) the Government of
Canada's premier research organization.
CMIC GROUP is a leading full function service Working with clients
solution
provider in Japan
Inspired by withofover
the spirit 7,000
"Start with employees located through
Integrity, Succeed in the
Action," Innovent's
Apeloa CDMO mission
is the contract is to discoverdevelopment,
discovery, and develop, and
manufacturing
Teijin Pharma is business of its parent
a fully integrated companycompany
healthcare Apeloa with
two core businesses of pharmaceuticals and home
Olon can offer complete integrated packages and services healthcare
to
support the full development of APIs
Sumitomo Pharma's goal is to create innovativebased on Olon strong
pharmaceutical
1) AGC is rapidlyproducts.
growing Psychiatry
pharmaceutical& Neurology
businessasthrough
well as
organicGROUP
CMIC technology development
is a leading and acquiring
full function company in
service solution
provider
DKSH is in Japan with
a leading over 7,000
healthcare employees
company located
in Asia in the
with 8,000
employees across 15
Chugai, a member marketsgroup,
of Roche and 6isbillion CHF in company
a Japanese sales.
focused
The Officeonofcreating innovative
Technology medicinal
Transfer manages products which
and promotes
tech transfer
Biolab is one opportunities
of the largest for the AP-HP
Brazilian (Assistance
pharmaceutical
companies among Brazil's top 10 pharmaceutical companies
Kowa Company, Ltd. (Kowa) is a privately-held, 130 year-old
Japanese corporation
Orion Corporation is a headquartered in Nagoya.
European, innovative, Kowa has
mid-sized
pharmaceutical company
Kyowa Kirin Group headquartered
companies in Finlandtowith
strive to contribute the a
health and well-being
Aristo Pharma of people
is a family ownedaround
company,the with
worldthe
by creating
headquarters in Berlin,
We are committed Germany.
to furthering It’s a fully
precision integrated
medicine and
personalised AIT treatments to address unmet
Thea is a pharma company specialized in ophtalmology. medical needs
World Wide Group
The Alfresa revenue is around
engaged 900M$ in 2022.
in a range of businesses from
the manufacture of APIs and manufacture
At Clarivate, we empower our Life Sciences and wholesale of
& Healthcare
customers to deliver
A partner with strongtreatments
commitment: that improve patient lives and
Servier
Pendopharm, a division of Pharmascience,company
is an independent pharmaceutical is a fully
integrated Canadian
<Out-licensing pharmaceutical company committed to
opportunities>
Blood
We areproducts
a global for transfusion
biopharma are used
company withinadamage
purposecontrol
to unite
science, technology
Research-based and talent
Japanese to get aheadcompany
pharmaceutical of diseasethat
develops,
Taiho Pharmaceutical, a subsidiary of Otsuka HoldingsofCo.,
manufactures and commercializes a variety
Ltd., is an R&D-driven
NO SERVICE PROVIDERSspecialty pharma focusing on the two
PLEASE
NO
STFC CMOis aPLEASE
world-leading research and innovation
organisation,
The NIHR helpswithindustry
a unique role
and within UKRI
charities (UK
to work in Research
partnership
with NHS hospitals and the UK's leading universities.
Maruho Co., Ltd. is a leading pharmaceutical company
specializing in dermatology
Recordati, established in Japan.
in 1926, We have
is a listed more than one
European
pharmaceutical company, with global sales equal to Euro
(Out-license: NO-13065)
We would
Fuso like to haveIndustries,
Pharmaceutical an out-licensing opportunityinof1937,
Ltd. Established a novel
and started our business
EXPERIENCE YOU CAN COUNT ON from the sale of glucose. Today, we
Grifols
Kissei isEngineering specializes
a R&D oriented Japanese in the field of
pharmaceutical company.
We have clinical and pre-clinical stage assets seeking
Bayshore Specialty Rx Ltd is one of the largest Canadian for a
owned
Eisai andLtd.
Co., operated health services company. We have been
At Eisai Inc.,
Sanofi’s vaccineshuman health care
business is our partners
is seeking goal. Wewho
givewill
ourshare
first
the
Reigcompany's pursuit ofpharmaceutical
Jofre is a Spanish innovation andcompany,
drive for excellence,
founded in
1929 and listed on the Spanish Stock Exchange
2021 Turnover was 399 mio €. 1662 employees. 40% sales market. RJ
force. itOur
Since main
was therapeutic
founded in 1929,areas are has
Esteve Allergy,
beenENT,
firmly
committed
>KM Biologics to excellence in healthcare, dedicating efforts to
...
UBE hascorporation
the following mainofbusiness
is one areas:
the largest Human
chemical Vaccines,in
companies
Japan, founded over
The Grünenthal Group 100 years
– an ago. In thefamily-owned,
independent, pharmaceutical
research-based,
Grifols is a leadingmid-size pharma company
global healthcare company headquartered
that developsin
plasma-derived medicines and other innovative
“Together, our passionate people drive innovative health
solutions
Ipsen sellsforover
all animals,
20 drugscontributing to115
in more than the future of our
countries, and has
a direct
Intas is acommercial presence global
vertically integrated in overcompany,
30 countries. Ipsen’s
leading in the
development, manufacturing
Headquartered and marketing
in St. Prex, Switzerland, of pharmaceutical
Ferring has in recent
years
Cancer expanded
Researchbeyond its traditional
UK (CRUK) European
is the world’s base: with
largest
independent funderpharmaceutical
Santen is a global of cancer research with an
company annual
focused on the
ophthalmic fields, "eye diseases", including pharmaceuticals,
Toray Group fuses nanotechnology into its operations, using
organic
For synthetic
Canada, LATAM chemistry,
and thepolymer chemistry
United States, and
Apobiologix has
an interestinin1968
Founded partnering on biosimilar
by a French and differentiated
veterinarian, Virbac is an small
independent pharmaceutical laboratory dedicated to animal
 News

https://www.shionogi.com/global/en/news.html

https://www.evotec.com/en/ir-news/news

https://www.mt-pharma.co.jp/e/release/index.php

https://www.yokogawa.com/news/press-releases/2021/2021-
11-02/

• Acquisition of global rights to pan RAF inhibitor

exarafenib from Kinnate Biopharma, currently in clinical
https://www.nitto.com/jp/en/
https://www.nittobiopharma.com/

London, 25 April 2024

The Group had a strong and encouraging start to the year,

Meiji has experienced successful partnership with Pfizer,

Sanofi, Novartis, Abbvie, Symphogen, Light Sciences, Nippon
https://news.westernu.ca/2023/04/western-to-revolutionize-
drug-development-for-brain-diseases-with-24m-federal-
https://www.uhncommercialization.ca/news/news-events

• FF-10850 (liposomal topotecan) has been granted the FDA

orphan drug designation for Merkel cell carcinoma in March

Followings are our recent in-licensing activities:

・Daridorexant: a novel orexin receptor antagonist for the
https://www.ferrer.com/en/We-acquire-worldwide-rights-to-
ASN90-an-O-GlcNAcase-inhibitor-to-treat-Progressive-

Alvogen acquires Korean Dream Pharma for US$ 187 million

http://www.alvogen.com/newsroom/read/alvogen-acquires-

FDA Approves HERCESSI for HER2-Overexpressing Gastric,

Gastroesophageal Cancers - May'24

https://www.menarini.com/en-us/

Sep 27, 2022: Teijin, J-TEC, National Cancer Center, and

Mitsui Fudosan to Establish Regenerative Medicine Platform
https://www.thetimes.co.uk/article/dundee-spins-away-from-
rivals-as-university-start-ups-graduate-s5x5h86wk

Recent Deal making track record in Medical dermatology

includes:
http://www.nrc-cnrc.gc.ca/eng/rd/hht/index.html

Apeloa invests in new facilities and technology platforms to

become a leader and a reliable partner for all pharma and

March 21, 2024

AGC Selected for “Innovation Momentum 2024: The Global
Visit www.bioworld.com for Clarivate's coverage of the latest
biopharma and medtech news, including actionable
https://servier.com/en/newsroom/

https://www.taiho.co.jp/en/

http://www.recordati.com/en/news_and_announcements/

Eisai started venture investment in 2019, aiming at

accelerating innovation in drug creation and establishment of

http://www.ipsen.com/medias/news/
 Primary therapeutic area(s) Secondary therapeutic area(s)

Cancer Carcinoma
Central nervousdisease
Dermatological system disease Non-epithelial
Hematological tumor
disease
Gastrointestinal disease
Gastrointestinal disease Neurological disease
Immune disorder
Infectious disease
Cardiovascular disease
Dermatological disease
Infectious disease Respiratory disease
Central nervous system disease Atrophy

Cardiovascular disease Gastrointestinal disease

Dermatological disease
Cardiovascular disease Genitourinary disease
Degeneration
Cardiovascular disease
Degeneration
Cardiovascular disease Cardiovascular disease
Genetic disorderdisease
Cardiovascular Gastrointestinal disease
Dermatological disease
Dermatological
Inflammatory disease
disease Infectious disease
Dermatological disease
Metabolic disorder
Cardiovascular disease
Dermatological disease
Cardiovascular disease
Endocrine disease
Dermatological disease
Genitourinary diseasefibrosis
Idiopathic pulmonary
Liver fibrosis
Gastrointestinal disease
Gynecology anddisease
Cardiovascular obstetrics
Genitourinary
Dermatologicaldisease
disease
Immune disorder
Andrology
Cardiovascular disease
Cardiovascular disease
Degeneration
Cardiovascular disease
Dermatological
Immune disorderdisease
Musculoskeletal disease
Cardiovascular disease
Dermatological
Prostate tumor disease
Skin tumor
Hematological disease
Immune disorder
Neurological disease
Degeneration
Endocrine disease
Cardiovascular disease
Immune disorder
Genitourinary disease
Infectious
Solid tumordisease
Gastrointestinal disease
Inflammatory disease
Neurological disease
Psychiatric disorder
Hematological disease
Inflammatory disease
Infectious disease
Neoplasm
Cardiovascular disease Dermatological disease
Gastrointestinal
Genitourinary disease
disease Genetic disorderdisease
Cardiovascular
Gynecology and obstetrics Immune disorder
Degeneration
Dermatological
Cardiovascular disease
disease
Dermatological disease
Neurological disease
Respiratory
Cancer disease Male tumor
Dermatological disease Metastasis
Endocrine
Andrology disease
Cardiovascular
Cardiovascular disease
disease Metabolic disorder
Endocrine disease
Gastrointestinal disease Neoplasm
Gynecology and obstetrics
Cardiovascular disease
Dermatological disease
Neurological disease Gynecology and obstetrics
Respiratorydisease
Endocrine disease Infectious disease
Neoplasm
Gastrointestinal disease
Immune disorder
Dermatological disease
Endocrine disease
Gastrointestinal disease Degeneration
Infectiousdisorder
Immune disease Hematological disease
Infectious disease
Cardiovascular disease
Dermatological disease
Genetic disorder
Respiratory disease
Cardiovascular disease
Dermatological
Ocular disease disease
Congenital heartdisease
Cardiovascular defect
Dermatological disease
Cardiovascular disease Genitourinary disease
Endocrine disease
Infectious disease Immune disorder
Community acquired
Dermatological respiratory tract infection
disease
Immune disorder
Dermatological disease
Gynecology anddisease
Gastrointestinal obstetrics Cardiovascular disease
Genetic disorder
Neurological disease Dermatological disease
Diabetes mellitus
Dermatological disease
Bullous skin disease
Cardiovascular disease
Degeneration
Genetic disorder
Infectious disease
Degeneration Cardiovascular disease
Genetic disorder
Hematological disease Dermatological disease
Autoimmune disease
Allergy Solid tumor
Osteopetrosis
Renal disease
Infectious disease Degeneration
Neoplasm Genetic disorder
Degeneration Cardiovascular disease
Genetic disorderdisease
Cardiovascular Dermatological
Cardiovascular disease
disease
Gynecology and obstetrics
Genetic disorder Dermatological disease
Hematological
Cardiovasculardisease
disease
Dermatological disease
Cardiovascular disease Gastrointestinal disease
Dermatological disease Genitourinary disease
Cardiovascular disease Gastrointestinal disease
Ocular disease
Breast tumor Infectious disease
Endometriosis
Hematological disease
Renal disease disease
Dermatological
Genitourinary disease
Ocular disease
Gastrointestinal disease
Genetic disorder
Cardiovascular disease
Neoplasm
Cardiovascular disease Cardiovascular disease
Dermatological
Injury disease Dermatological disease
Surgical procedure
Genetic disorder
Immunedisease
Ocular disorder
Myopia
Cancer Dermatological disease
Cardiovascular disease Genitourinary disease
Dermatological
Immune disorder disease
Infectious disease
Dermatological disease
Immune disorder
Cardiovascular disease
Endocrine disease
Cardiovascular disease Metabolic syndrome X
Metabolic
Adrenal disorder
gland hyperfunction Hyperlipidemia
Adrenal gland hypofunction
Urinary tract disease Gastrointestinal disease
Renal disease Gynecology and obstetrics
Neurological disease
Breast tumor
Infectious disease
Respiratory syncytial
Dermatological diseasevirus infection
Musculoskeletal disease
Dermatological disease Dermatological disease
Endocrine disease
Neoplasm Respiratory disease
Ocular
Geneticdisease
disorder
Inflammatory disease
Renal disease
Osteoarthritis
Peripheral
Immune neuropathy
disorder
Infectious disease
Cardiovascular disease
Dermatological
Degeneration disease
Endocrine disease
Gastrointestinal disease Endocrine disease
Infertility
Neoplasm
Cancer
Ocular disease
Cancer
Solid tumor
Cardiovascular disease Degeneration
Dermatological disease Metabolic disorder
 Number of employees Founded Ownership Licensing objectives

More than 10,000 2005 Public

More than 10,000 Public Seeking out-licensing opportunities
1,000 to 10,000 1948 Private Seeking in-licensing
Seeking in-licensing opportunities
opportunities
1,000 to 10,000 2008 Public Seeking in-licensing opportunities
1,000 to 10,000 2001 Public Seeking in-licensing opportunities
1,000 to 10,000 1878 Public Seeking out-licensing opportunities
More than 10,000 1934 Public Seeking in-licensing
Seeking out-licensingopportunities
opportunities
More than 10,000 1940 Public
More than 10,000 1885 Private
1,000 to 10,000 1997 Private Seeking in-licensing opportunities
1,000 to 10,000 1897 Other Seeking out-licensing opportunities
1,000 to 10,000 1993 Public Seeking out-licensing opportunities
More than 10,000 1964 Public Seeking in-licensing opportunities
1,000 to 10,000 2007 Public Seeking out-licensing
Seeking opportunities
in-licensing opportunities
1,000 to 10,000 1912 Private Seeking in-licensing opportunities
1,000 to 10,000 1966 Private Seeking
Seeking out-licensing
out-licensing opportunities
opportunities
More than 10,000 1915 Public Seeking in-licensing opportunities
1,000 to 10,000 1836 Private Seeking in-licensing opportunities
1,000 to 10,000 1987 Private
1,000 to 10,000 1961 Private Seeking in-licensing opportunities
1,000 to 10,000 1918 Public Seeking out-licensing opportunities
1,000 to 10,000 1976 Public
1,000 to 10,000 1964 Public Seeking in-licensing opportunities
1,000 to 10,000 1946 Public Seeking in-licensing opportunities
1,000 to 10,000 1948 Public Seeking
Seeking out-licensing opportunities
in-licensing opportunities
More than 10,000 1912 Public Seeking out-licensing
Seeking opportunities
in-licensing opportunities
More than 10,000 1885 Private
1,000 to 10,000 1978 Public Seeking in-licensing opportunities
1,000 to 10,000 2007 Seeking out-licensing opportunities
More than 10,000 1996 Public Seeking in-licensing opportunities
1,000 to 10,000 2010 Private Seeking in-licensing opportunities
1,000 to 10,000 1916 Public Seeking in-licensing opportunities
More than 10,000 1878 Public Seeking out-licensing opportunities
More than 10,000 1972 Private Seeking in-licensing opportunities
More than 10,000 Seeking out-licensing opportunities
1,000 to 10,000 1923 Public Seeking investment
Seeking in-licensing opportunities
More than 10,000 2006 Public Seeking out-licensing opportunities
1,000 to 10,000 1985 Public Seeking
Seeking investment
out-licensing opportunities
1,000 to 10,000 Private Seeking in-licensing
Seeking in-licensing opportunities
opportunities
1,000 to 10,000 2003 Private Seeking in-licensing opportunities
1,000 to 10,000 2000 Public Seeking out-licensing opportunities
1,000 to 10,000 1913 Public Seeking out-licensing opportunities
1,000 to 10,000 1977 Private Seeking in-licensing
Seeking in-licensing opportunities
opportunities
Seeking out-licensing opportunities
1,000 to 10,000 1966 Other Seeking out-licensing opportunities
More than 10,000 1966 Public Seeking investment
1,000 to 10,000 2001 Public Seeking in-licensing opportunities
1,000 to 10,000 1959 Private Seeking in-licensing opportunities
1,000 to 10,000 1916 Public Seeking out-licensing
Seeking opportunities
in-licensing opportunities
More than 10,000 1895 Private Seeking in-licensing opportunities
1,000 to 10,000 1966 Private Seeking out-licensing opportunities
1,000 to 10,000 1966 Public Seeking in-licensing
Seeking in-licensing opportunities
opportunities
1,000 to 10,000 1955 Public Seeking in-licensing opportunities
1,000 to 10,000 1974 Private Seeking out-licensing
Seeking opportunities
in-licensing opportunities
More than 10,000 1996 Public
1,000 to 10,000 1906 Private Seeking in-licensing opportunities
More than 10,000 2005 Private Seeking in-licensing opportunities
1,000 to 10,000 1947 Private Seeking in-licensing opportunities
1,000 to 10,000 1972 Private Seeking in-licensing opportunities
More than 10,000 1900 Public Seeking out-licensing opportunities
1,000 to 10,000 1928 Public Seeking out-licensing
Seeking investment opportunities
1,000 to 10,000 2012 Public Seeking investment
More than 10,000 1886 Private Seeking in-licensing opportunities
1,000 to 10,000 1909 Public Seeking out-licensing opportunities
1,000 to 10,000 1935 Private Seeking in-licensing opportunities
1,000 to 10,000 1964 Private
More than 10,000 1918 Public Seeking in-licensing opportunities
1,000 to 10,000 1881 Other Seeking
Seeking out-licensing
investment opportunities
1,000 to 10,000 1969 Private Seeking out-licensing
Seeking opportunities
in-licensing opportunities
1,000 to 10,000 1901 Other Seeking in-licensing opportunities
More than 10,000 1977 Public Seeking
Seeking out-licensing opportunities
in-licensing opportunities
1,000 to 10,000 1944 Public Seeking out-licensing
Seeking opportunities
in-licensing opportunities
1,000 to 10,000 1953 Private Seeking in-licensing opportunities
1,000 to 10,000 1887 Public Seeking
Seeking out-licensing
out-licensing opportunities
opportunities
1,000 to 10,000 1943 Public Seeking in-licensing opportunities
Seeking in-licensing opportunities
1,000 to 10,000 1958 Private Seeking in-licensing opportunities
1,000 to 10,000 1916 Other
1,000 to 10,000 1992 Public
1,000 to 10,000 2011 Public Seeking in-licensing opportunities
1,000 to 10,000 1989 Seeking out-licensing opportunities
1,000 to 10,000 2002 Public Seeking in-licensing opportunities
1,000 to 10,000 1907 Private Seeking out-licensing opportunities
1,000 to 10,000 2005 Public Seeking in-licensing opportunities
More than 10,000 1907 Public Seeking
Seeking out-licensing opportunities
in-licensing opportunities
1,000 to 10,000 1992 Public Seeking investment
More than 10,000 1865 Public
1,000 to 10,000 1925 Public Seeking out-licensing opportunities
More than 10,000 Public Seeking
Seeking in-licensing
out-licensingopportunities
opportunities
1,000 to 10,000 1997 Private Seeking investment
Seeking in-licensing opportunities
1,000 to 10,000 1894 Private Seeking in-licensing opportunities
1,000 to 10,000 1917 Public Seeking in-licensing opportunities
1,000 to 10,000 1949 Public
1,000 to 10,000 2008 Private Seeking in-licensing opportunities
1,000 to 10,000 Private Seeking in-licensing opportunities
1,000 to 10,000 1994 Private Seeking out-licensing
Seeking opportunities
in-licensing opportunities
More than 10,000 2003 Public Seeking in-licensing opportunities
1,000 to 10,000 1960 Public Seeking in-licensing opportunities
More than 10,000 1954 Private Seeking
Seeking out-licensing opportunities
in-licensing opportunities
1,000 to 10,000 1983 Private Seeking out-licensing opportunities
Seeking in-licensing opportunities
1,000 to 10,000 2012 Private Seeking out-licensing opportunities
More than 10,000 1715 Public Seeking in-licensing opportunities
1,000 to 10,000 1947 Private
1,000 to 10,000 1963 Other Seeking in-licensing opportunities
1,000 to 10,000 1938 Private Seeking out-licensing
Seeking opportunities
in-licensing opportunities
1,000 to 10,000 2007 Public Seeking investment
More than 10,000 2006 Public Seeking in-licensing opportunities
1,000 to 10,000 1915 Private Seeking in-licensing opportunities
1,000 to 10,000 1926 Public Seeking in-licensing opportunities
1,000 to 10,000 1921 Public Seeking out-licensing opportunities
1,000 to 10,000 1937 Private Seeking in-licensing opportunities
More than 10,000 1940 Public
1,000 to 10,000 1946 Public Seeking in-licensing opportunities
More than 10,000 1966 Private Seeking out-licensing opportunities
1,000 to 10,000 1941 Public
More than 10,000 1994 Public
1,000 to 10,000 1929 Private Seeking out-licensing opportunities
1,000 to 10,000 1933 Public Seeking in-licensing opportunities
1,000 to 10,000 1929 Private Seeking in-licensing opportunities
1,000 to 10,000 2018 Private Seeking in-licensing opportunities
1,000 to 10,000 Public Seeking out-licensing
Seeking out-licensing opportunities
opportunities
1,000 to 10,000 1946 Private Seeking in-licensing opportunities
More than 10,000 1909 Public
1,000 to 10,000 1999 Private
1,000 to 10,000 1929 Public
More than 10,000 Private Seeking out-licensing opportunities
1,000 to 10,000 1965 Private
1,000 to 10,000 Private Seeking in-licensing opportunities
1,000 to 10,000 1890 Public Seeking out-licensing
Seeking opportunities
in-licensing opportunities
More than 10,000 1926 Public Seeking out-licensing opportunities
1,000 to 10,000 1974 Private Seeking in-licensing opportunities
1,000 to 10,000 1968 Private Seeking in-licensing opportunities
 Company objectives Ticker

4568:TSE
SAN
To build the pipeline in our key therapeutic areas,
Gastrointestinal
Identify clinical assets and technologies for in-licensing that BNTX
support BioNTech's vision
Licensing and Acquisition (mRNA, cell and gene, antibodies, HYPE3
Seeking partnering oppotunities for pre-clinical and clinical TYO: 4507
stage assets for global and Japanese markets, we focus on: TYO: 4901
WE ARE ENGINEERS SPECIALIZED IN PROJECT GRFS
MANAGEMENT IN
Biolab is committed to seeking out and investing in cutting-
edge patented
New drug drugs and
and device technologies that can improve the
development
We believe that through collaboration, we can advance drug EVT; EVO
discovery and development
We are looking to in-license to make a real
compounds difference
in late in the
preclinical or 4578
clinical development for the following therapeutic areas:
・Seeking new products in the United States and Japan 4508
As for Consumer Health Care (CHC) business, we are looking
for the partners
In-licensing for belowinnovative
of late-stage opportunities. We including
assets, are open NCEs
to joint
and
We arevalue-added products, forwho
seeking collaborators Brazil
areand LatAm.
willing to co-develop Tokyo Stock Exchange 6841
the new application of bioprocess manufacturing, business
In Licensing , Co-development and M&A opportunities BLAU3
Pierre Fabre’s mission is to take care of life by designing and
developing innovative
Nitto develops industrysolutions inspired
leading Lipid by consumers
Nanoparticle and
Delivery
systems for nucleic acids, including mRNA, siRNA and DNA.
Fuji is actively pursuing in-licensing and co-development TSE4554
opportunities across all major
Partnering Risperidone ISM® areas of women’s health, as ROVI
scouting potential in/out-licensing partners 4521 (TSE)
In-Licensing and/or acquisition and/or co-development of Rx FRE.DE
Generics,
We embraceGenerics plusof
the power (Gx+; Genericand
partnership plus) and Value
diversity of minds
across the life-science community and have around
We are searching for late-stage in-licensing opportunities 50% ofand HIK.L
acquisition of marketed products in the following
We are strongly dedicated to creating value by developingareas:
and delivering
At Novartis, wequality
believeproducts that make
that biomedical human lives
innovation better, NVS
will have
an unparalleled
Explore Partneringimpact on all humankind.
opportunities, We are
In-licensing, andexcited at
Unlicensed
Sales, in addition to supporting the clinical supply
We seek new attractive in-licensing opportunities within chain.
therapeutic
Our objective areas not onlyUniversity
at Western those in which we have shown
is to collaborate with our
leaders
Partneringin pharma, biotech,
objectives: and visionary
in-licensing; partners totech
co-development;
transfer
As a catalyst for accelerating the translation of UHN’s world-
class
Kyorinresearch, discovery
is attending the BIOand clinical innovation
International into products 4560
partnering
conference with two objectives:
• Seeking out-licensing and investment opportunities for our FUJIY
clinical stage oncology pipeline 2914
Looking for inorganic growth opportunities via both acquisition
and licensing
CureVac strives to create transformative medicines to protect CVAC
and improveLicensing.
Partnering, people’s lives. 4534
Please
We are note: no partners
seeking vendor orinterested
supplier meetings
in: will be accepted.
At Bio the University of Bath would like to gain introductions
to
Wepotential collaborators,
are looking for industrylicensees
researchand investors.
partnerships!
Licensing and Acquisition HYPE3
IN-LICENSING of clinical stage programs in the therapeutic
areas:
Cancer Therapeutics and Diagnostics, Research 4272
collaboration
Seeking partners to co-develop or commercialize difficult to
make generics, specialty brands and consumer health assets
Seeking in-licensing opportunities for the late stage products
in especially Oncology, CNS, Nephrology, Orphan/Rare 4559
In-Licensing, collaborations, partnerships, and acquisitions of
late stage, submission
At Novartis, we believeready, or marketed
that biomedical productswill
innovation across
have NVS
an unparalleled impact on all humankind. We are excited at

In-licensing of novel therapies and biosimilars

Cristalia is searching for strategic partnerships, focused on
hard-to-make, innovative and
Public Health. Biomedical anddifferentiated products.
clinical research, Cristalia
technological
development of
Out-licensing andhealth products.
finding Production
collaboration of vaccines,
opportunities of Tokyo
Medical and Dental University technologies with LON: DATA

We are looking for partnering opportunities related to our 2802

proprietaryand
In-license technologies and contract
acquire therapies manufacturing
for the services
US and European
markets.
Introduction of new therapies in the Brazilian market with
radical or incremental
We Teijin would like toinnovation in several
offer the following areas, such as
business TSE 3401
opportunities;
Our main Goals for Bio-International are:
• - Licensing
In Establish innovative
partnershipproducts
with investors to support
for Brazilian our
market

Glenmark is pursuing a partnering strategy for key innovative GLENMARK

assets to de-risk
Hisamitsu clinical development
Pharmaceutical through
is seeking for a shared
the in-licensing TYO: 4530
opportunities
We and collaboration
welcome requests on Hisamitsu's
for meetings products and
to discuss in-licensing,
acquisition, co-development, co-promotion and
-Set up partnerships for SN-001 program to develop distribution
it outside 4021.T
Japan.
Almirall External Innovation & Licensing team is actively ALM
seeking collaborations
Libbs offers its partnersandthe breakthrough
advantages ofin-licensing
commitment to the
long run and a solid organization with marketing capabilities,
To seek companies interested to bring developing and 2309
commercial productsside,
1) On the in-bound (pharmaceuticals, regenerative
Innovent is looking to in-license or 1801.HK
otherwise acquire rights to commercial or late-stage oncology,
Alliance Opportunities in pharmaceutical business.
We have been expanding our product line ups in the focused

Exploring collaboration partners and strategic partners in the 5201

following
To areas: HPAPI
seek companies (high potency
interested to bringAPI) CMO / F&F,
developing and 2309
commercial products (pharmaceuticals,
In-licensing of pharmaceutical products regenerative
Products and brand acquisitions
[Out-License] 4519
-Partnering,
Antibody Engineering Technology:
Licensing, R&D collaboration
Biolab is committed to seeking out and investing in cutting-
edge patented drugs and technologies that can improve the
Acquire, in-license, or partner to launch new products in the
USA
Orionand Japan.for in-licensing, assets to acquire and
is looking
collaboration
We are seeking opportunities in oncology,
for in-licensing pain, neurological
and/or collaboration TYO: 4151
opportunities at early stage from discovery to clinical
Aristo is seeking small molecule Value Added Medicines stage in
(hybrids, 505(b)2) for potential in-licensing to strengthen its STAGR

We are now looking for IN-LICENSING opportunities in TYO: 2784

pharmaceuticals, diagnostics, and medical devices
At Clarivate, we empower our Life Sciences & Healthcare in clinical CLVT
customers to deliver treatments that
PLEASE REFER TO THE INFORMATION LEAFLET improve patient
ENCLOSED
In-licensing orINacquiring
THE CONTENT SECTION
innovative productsOFforTHIS PAGE
Canada and
potentially other
Out-licensing territories, Providing CDMO services for
or co-development
GSK

<Business Development Strategy and Priorities>

In-licensing
- In-licensingScope
late stage assets to market in EU in Women's
Health, CNS, Dermatology, Cardiovascular, Rare and orphan
To support the life science industry, including but not limited
to Pharma, Biotech,
In-licensing Medtech, IVD, Digital and Imaging, carry
opportunity
Prescription
Our businessdrug, aesthetic strategy
development agents, medical
focuses device and inor REC.MI
on licensing
acquiring:

WE ARE ENGINEERS SPECIALIZED IN PROJECT GRFS

MANAGEMENT IN 4547
Let us help you commercialize your company or product into
the find
To Canadian market. partners, especially in oncology and 4523
the collaboration
neurology areas, to find out licensing/alliance partner of our SAN
Out Licenisng our portfolio in osteoarthritis&musculoskeletal RJF
and
•Faesdermatology
is seeking for a) in-licensing opportunities of late-stage FAES
(approved,IN:
Licensing pending approval and Phase III) developed
•Our
Wecompany
are interested to in-license
is actively late
searching stage
new specialty products,
business
opportunities both in domestic
Seeking out-licensing and international
opportunities markets.
and collaborative 4208
research
Let’s identify the next breakthrough therapies together.
We are looking for in-licensing opportunities, co-dev
partnerships
We are looking or for:
any other type of deal structure that could IPN
•OfferNew indicationsportfolio
our Biosimilar for existing
and products
pipeline, in our portfolio
co-development
agreements.
We facilitate impactful, mutually beneficial relationships
between Cancer Research
Seeking investment, UK and
in-licensing the
and biopharmaceutical
collaboration opportunity 4536 (Tokyo Stock Exchange)
At this Bio International, Toray is looking for the potential 3402
partners for our Pharmaceutical
Commercialization of biosimilarsAssets in the field
& differentiated of
small
molecules
In-license delivering
innovationsquality and value
applicable for patients
to animal health and
(see below VIRP
our areas of interest).
Market cap ($M) Last funding round(s) Total funding ($M)

22000 Other
6
15000

480

3000
22326

1200
5545

5000

10525

400

35000

6220

1200
22000
71000

776
 3.8

1700

2250

1000

2000

774

2069

1500
3200

440

300
10000 1000

600

300

59000

480
 2972

116840

12019
1300

11500

70

1000

20888

3500
15000

2.3
 Website Main email

http://dsi.com/business-development
https://www.sanofi.com
http://www.alfasigma.com/
www.biontech.de [email protected]
http://hyperapharma.com.br/ [email protected]
http://www.shionogi.co.jp/en/
[email protected]
www.grifolsengineering.com
www.bioxcellence.com [email protected]
www.biolabfarma.com.br [email protected]
https://www.saci.kyoto-u.ac.jp/en/ [email protected]
www.evotec.com [email protected]
https://www.otsuka.com/en/
http://www.mt-pharma.co.jp/
http://www.taisho.co.jp/en/
www.ache.com.br [email protected]
https://www.yokogawa.com [email protected]
https://acino.swiss/ [email protected]
www.blau.com [email protected]
www.pierre-fabre.com
https://www.nitto.com/jp/en/ [email protected]
https://www.bio.fiocruz.br/index.php/en-us/bio-eng [email protected]
www.fujipharma.jp [email protected]
www.rovi.es [email protected]
https://www.kaken.co.jp/english/
www.fresenius-kabi.com
https://www.boehringer-ingelheim.com/
http://www.hikma.com [email protected]
https://extrovis.com/ [email protected]
https://www.novartis.com/partnering
https://www.clinigengroup.com/ [email protected]
http://www.meiji.com/global/
https://uwo.ca/ [email protected]
www.eurofarma.com.br [email protected]
www.uhncommercialization.ca [email protected]
https://www.kyorin-pharm.co.jp/en/
[email protected]
https://www.jt.com/about/division/pharma/index.html
https://www.neuraxpharm.com/
http://www.asahikasei-pharma.co.jp/en/index.html
www.curevac.com [email protected]
http://www.mochida.co.jp/english/
www.insudpharma.com
www.bath.ac.uk/ris/ [email protected]
https://research.ucalgary.ca/health-life-sciences-partnerships [email protected]
http://hyperapharma.com.br/ [email protected]
www.ferrer.com/en
http://www.nipponkayaku.co.jp/english/
https://www.stada.com/
www.ache.com.br [email protected]
www.alvogen.com [email protected]
http://www.zeria.co.jp/english/index.html
https://www.apotex.com/global
https://www.novartis.com/about/manufacturing/contract-manufacturing
[email protected]
https://www.zambon.com
http://accord-healthcare.com
www.teuto.com.br [email protected]
http://www.cristalia.com.br/ [email protected]
htts://www.fiocruz.br [email protected]
http://www.tmd.ac.jp/english/ [email protected]
https://www.globaldata.com/industries-we-cover/pharmaceutical/
http://www.menarini.com
https://ajibio-pharma.ajinomoto.com/
https://www.chiesi.com/en/ [email protected]
www.ems.com.br [email protected]
https://www.teijin-cdmo.com/ [email protected]
https://www.dundee.ac.uk/research-innovation/ [email protected]
www.apsen.com.br [email protected]
http://butantan.gov.br/instituto-butantan [email protected]
www.glenmarkpharma.com
www.hisamitsu.co.jp/
https://www.biocodex.com/en/
http://www.nissanchem.co.jp/eng/
www.almirall.com [email protected]
www.libbs.com.br [email protected]
http://www.nrc-cnrc.gc.ca/eng/rd/hht/index.html [email protected]
https://en.cmicgroup.com/ [email protected]
innoventbio.com [email protected]
www.apeloacdmo.com
https://www.teijin.com/products/health-care/
http://www.olonspa.com/
https://www.sumitomo-pharma.com/
https://www.agc.com/en/
https://en.cmicgroup.com/ [email protected]
[email protected]
www.chugai-pharm.co.jp/english [email protected]
https://www.aphp.fr/ [email protected]
www.biolabfarma.com.br [email protected]
https://www.kowa.co.jp/eng/business/health/index.html [email protected]
http://orion.fi/en/
https://www.kyowakirin.com/index.html
https://www.aristo-pharma.de/en [email protected]
http://www.stallergenes.fr
https://www.theaopeninnovation.com/
https://www.alfresa.com/eng/ [email protected]
https://clarivate.com/ [email protected]
http://www.servier.com/
https://www.pharmascience.com/
http://jbpo.or.jp/english/ [email protected]
http://www.gsk.com/
http://www.senju.co.jp/english/ [email protected]
https://www.taiho.co.jp/en/ [email protected]
www.italfarmaco.com
www.linkedin.com/in/adrianjhill [email protected]
https://www.nihr.ac.uk/partners-and-industry/industry/ [email protected]
http://www.maruho.co.jp/english/
http://www.recordati.com/en/ [email protected]
http://www.otsukakj.jp/en/ [email protected]
https://www.fuso-pharm.co.jp/cnt/en/
www.grifols.com
http://www.kissei.co.jp/e_contents/index.html [email protected]
www.bayshore.ca [email protected]
https://www.eisai.com/index.html
www.sanofi.com/en/your-health/vaccines
www.reigjofre.com
http://faesfarma.com/en/ [email protected]
www.esteve.es
www.kmbiologics.com/en [email protected]
https://www.ube.co.jp/ube/en/index.html [email protected]
www.grunenthal.com [email protected]
http://www.grifols.com/
www.ceva.com [email protected]
http://www.ipsen.com
[email protected]
www.ferring.com
https://www.cancerresearchhorizons.com/ [email protected]
https://www.santen.com/en/
http://www.toray.com/
www1.apotex.com/global [email protected]
www.virbac.com [email protected]
 Main phone Country State

Japan Tokyo
+32468145709 France
Italy
+49-6131-9084-0 Germany
+ 55 11 3627-4000 Brazil SÃO PAULO
+81-6-6202-2161 Japan Osaka
+81-3-6271-2395 Japan
Spain Spain
+49 (0) 6132 770 Germany
+ 55 11 3573-6276 Brazil SP
+81-75-751-4709 Japan Kyoto-fu
Germany Hamburg
+81 (0)3-6717-1410 Japan
Japan
Japan
551126088773 Brazil São Paulo
+81-422-52-5582 Japan
Switzerland
+551146159400 Brazil São Paulo
France
+81-50-3815-8522 Japan Osaka
Brazil Rio de Janeiro
+81-3-3556-3344 Japan Tokyo
+34 91 375 62 30 Spain
+81-3-5977-5001 Japan
Germany
Germany
United Kingdom United Kingdom
+91-9618181612 Switzerland Baar
Switzerland
:+44 (0) 1283 495 010 United Kingdom Staffordshire
Japan Tokyo
519-661-2111 ext. 87380 Canada Ontario
551150908735 Brazil Sao Paulo
416 581 7410 Canada Ontario
+81-3-6374-9700 Japan Tokyo
+1-617-945-3763 Japan Tokyo
Japan Tokyo
+34 93 475 96 00 Spain
+81-3-6699-3600 Japan
+49(0)7071 9883-0 Germany Baden-Württemberg
Japan
Spain Madrid
+44 (0) 7837690860 United Kingdom England
Canada AB
+ 55 11 3627-4000 Brazil SÃO PAULO
+34 93 600 3700 Spain Province of Barcelona
+81-3-6731-5200 Japan Tokyo
Germany Hessen
551126088773 Brazil São Paulo
United Kingdom
03-3663-2351 Japan
Canada
Switzerland
Switzerland
United Kingdom
5562981390631 Brazil
+55 11 98799-3286 Brazil São Paulo
Brazil RJ
+81-70-3986-9581 Japan Bunkyo
United Kingdom
Italy
Japan
Italy
Brazil São Paulo
+81 3 3506 4359 Japan Tokyo
+441382386593 United Kingdom
+551156455046 Brazil São Paulo
+551126279511 Brazil Sao Paulo
Germany Bavaria
Japan Tokyo
France
+81-3-4463-8370 Japan
+34 93 2913745 Spain Barcelona
0800 013 5044 Brazil São Paulo
514-496-6211 Canada Ontario
81-36779-8024 Japan Tokyo
+ 44 793 2661 726 United Kingdom
+4917662007493 Germany
Japan
Italy
Japan Tokyo
Japan Tokyo
81-36779-8024 Japan Tokyo
Switzerland
Japan Tokyo
France
+ 55 11 3573-6276 Brazil SP
 Japan
Finland
+81-3-3282-0917 Japan
Germany
01 55 59 20 60 France
France
+818043806147 Japan Tokyo
+44 2074334000 United Kingdom London
France France
Canada Quebec
+81-3-6435-6513 Japan
United Kingdom
+81-6-6201-9698 Japan Osaka
+81-3-3294-4524 Japan
+390264433319 Italy
+447923241396 United Kingdom Oxfordshire
United Kingdom
+81663718876 Japan
+39 02 487871 Italy Lombardy
+81-88-685-1151 Japan Tokushima
+81 669691131 Japan
Spain Spain
+81-(0)263-25-9081 Japan Nagano Prefecture
647 746 8455 Canada Ontario
+81338175113 Japan
France France
Spain
900-4650-153 Spain Madrid
Spain
+81-96-344-2755 Japan Kumamoto pref.
81-80-8230-2912 Japan
+49 241 569-2985 Germany NRW
Spain spain
+33 5 57 55 67 42 France Libourne
France Île-de-France
+34637355489 Spain
+41 58 301 00 00 Switzerland Saint Prex
United Kingdom
+81-6-6321-7000 Japan
+81-3-3245-5111 Japan Kanagawa
416-749-9300 Canada Ontario
+33 4 92 08 71 00 France
 City Street address

Tokyo 3-5-1 Nihonbashi Honcho, Chuo-ku

Paris
Bologna
Mainz An der Goldgrube 12
SÃO PAULO Av. Magalhães de Castro, 4800 - Continental Tower - 24th
Osaka floor
1-8, Doshomachi 3-chome, Chuo-ku
Tokyo 7-3, Akasaka 9-Chome Minato-ku
Sant Cugat del Vallès (Barcelona) Avda. Generalitat, 152-158
Ingelheim Binger Strasse 173
Sao Paulo Av Faria Lima 4509 14º floor
Kyoto Kyoto University Hospital Institute for Advancement of Clinical
Hamburg and Translational
Essener Bogen 7 Science
Tokyo 2-16-4 Konan, Minato-ku

Tokyo 3-24-1, Takada, Toshima-ku

Guarulhos Rodovia Presidente Dutra, Km 222
Tokyo 2-9-32 Nakacho, Musashino

Cotia Rodovia Raposo Tavares Km 30,5 Nr 2833, Barro Branco,

Boulogne-Billancourt Cotia,
33 avenue Emile Zola
Ibaraki 1-1-2 Shimohozumi
Rio de Janeiro Avenida Brasil 4365, Centro Administrativo Vinícius
Tokyo Fonseca, Manguinhos
5-7 Sanbancho, Chiyoda-ku
Madrid Julian Camarillo 35
Tokyo 2-28-8, Honkomagome, Bunkyo-ku
Bad Homburg Siemensstr. 15

London 1 New Burlington Place

Bahnhof-Park 4
Basel
Burton on Trent Picairn House, Crown Square, First Avenue
Tokyo 2-4-16, Kyobashi, Chuo-ku
London 100 Collip Circle, Suite 105
Sao Paulo Rua Brito Peixoto, 554
Toronto 101 College Street
Tokyo 1-3-7, Otemachi, Chiyoda-ku
Minato-ku 7-3, Akasaka 9-chome
Tokyo 3-4-1, Nihonbashi-honcho, Chuo-ku
Barcelona Avinguda de Barcelona 69, Sant Joan Despi
Tokyo 1-1-2 Yurakucho, Chiyoda-ku
Tuebingen Friedrich-Miescher-Str. 15
Tokyo 7, Yotsuya 1-chome, Shinjuku-ku
Madrid
Bath Claverton Down
Calgary 2500 University Drive NW.
SÃO PAULO Av. Magalhães de Castro, 4800 - Continental Tower - 24th
Barcelona floor
Avda. Diagonal, 549
Chiyoda-ku 1-1, Marunouchi 2-chome
Bad Vilbel Stadastraße 2-18
Guarulhos Rodovia Presidente Dutra, Km 222
London 3rd Floor, Kings House, 174 Hammersmith Rd,
Tokyo Hammersmith, London
10-11, Nihonbashi W6 7JP, Chuo-ku
Kobuna-cho, United Kingdom

Basel

London 319 Sage House, Pinner Road, North Harrow,UK

Campinas, SP
Rio de Janeiro Av. Brasil 4365 Manguinhos
Tokyo 1-5-45 Yushima
London John Carpenter House, John Carpenter Street

Tokyo 15-1, Kyobashi 1-chome, Chuo-ku

Parma
Hortolândia Rod Jornalista Francisco A. Proença, Km 08
Tokyo 3-2-1, Kasumigaseki, Chiyoda-ku
Dundee School of Life Sciences, University of Dundee
São Paulo
Sao Paulo Avenida Vital Brasil, 1500
Groebenzell Industriestr . 31
Tokyo Marunouchi 2-4-1, Chiyoda-ku
Gentilly 22, rue des Aqueducs
Tokyo 5-1, Nihonbashi 2-chome, Chuo-ku
Barcelona General MItre, 151
São Paulo Av Marques de Sao Vicente 2219
Ottawa 1200 Montreal Road
Tokyo Hamamatsucho Bldg., 1-1-1 Shibaura, Minato-ku
LONDON Registered Address 1 Vine Street
Frankfurt
Tokyo Kasumigaseki Common Gate West Tower, 2-1, Kasumigaseki
Rodano (MI) 3-chome, Chiyoda-ku
Strada Rivoltana km6/7
Tokyo 13-1, Kyobashi 1-Chome, Chuo-ku
Chiyoda-ku Shin-Marunouchi Bldg, 1-5-1 Marunouchi
Tokyo Hamamatsucho Bldg., 1-1-1 Shibaura, Minato-ku

Chuo-ku, Tokyo 1-1 Nihonbashi- Muromachi 2-Chome

Paris
Sao Paulo Av Faria Lima 4509 14º floor
Tokyo 4-14, Nihonbashi-honcho 3-chome, Chuo-ku
Espoo P.O. Box 65
Tokyo Otemachi Financial City, Grand Cube, 1-9-2 Otemachi,
Chiyoda-ku
Wallenroderstr. 8-10
Antony 6 rue Alexis de Tocqueville
Clermont Ferrand 12 rue Louis Blériot
Tokyo 1-3, 1-chome, Ote-machi, Chiyoda-ku
London 70 St Mary Axe
SURESNES 50 rue Carnot
Montreal
Tokyo 15F Tamachi Station TowerN, 3-1-1 Shibaura, Minato-ku
Middlesex 980 Great West Road, Brentford
Osaka 3-1-9, Kawara-machi, Chuo-ku
Tokyo 1-27, kandanishiki-cho, Chiyoda-ku, Tokyo 101-8444 Japan
Cinisello Balsamo (Milano) Via dei Lavoratori, 54
Didcot, Oxfordshire UKRI, STFC, R71, Harwell campus,
London
Osaka 1-5-21 Nakatsu, Kita-ku
Milano 1, Via Civitali
Naruto 115 Kuguhara, Tateiwa, Muya-cho
Osaka 2-3-11, Morinomiya, Joto-ku, Osaka
Sant Cugat del Vallès (Barcelona) Avda. Generalitat, 152-158
Matsumoto City 19-48, Yoshino
Mississauga 2101 Hadwen Road
Tokyo 4-6-10 Koishikawa, Bunkyo-ku
Lyon 2, Avenue Pont Pasteur

Madrid Parque Empresarial Cristalia Edif 2 - 2º Izquierda. C/ Vía de

Barcelona los Poblados
Passeig de la Zona Franca 109
Kumamoto 1-6-1 Okubo, Kita-ku,
Yamaguchi 1978-5, Kogushi, Ube
Aachen Zieglerstr. 6
BARCELONA Avda de la Generalitat, 152,158. Sant Cugat del Valles
Libourne ZI La Ballastiere
Boulogne-Billancourt 65 Quai Georges Gorse
Barcelona
Saint-Prex Chemin de la Vergognausaz 50
London 2 Redman Place, London
Osaka 4-20, Ofukacho, Kita-ku
Kamakura Kamakura Tebiro 6-10-1
Toronto
Carros Cedex 13E RUE LID - BP27
 Postal code Created date/time Last updated date/time

103-8426 03/30/2024 1:55 AM 06/02/2024 10:26 AM

03/11/2024 9:45 PM 06/01/2024 12:22 AM
03/25/2024 11:51 PM 05/30/2024 6:46 PM
65131 02/23/2024 1:26 AM 05/29/2024 9:27 PM
05676-120 04/16/2024 1:51 AM 05/28/2024 4:45 PM
541-0045 02/23/2024 3:14 AM 05/28/2024 4:06 PM
107-0052 05/04/2024 1:59 AM 05/28/2024 7:14 AM
08174 05/14/2024 1:39 AM 05/27/2024 7:42 PM
55216 03/11/2024 9:44 PM 05/27/2024 7:40 PM
04538133 03/07/2024 8:03 PM 05/27/2024 6:32 PM
606-8507 04/16/2024 7:37 PM 05/24/2024 7:37 PM
22419 03/25/2024 7:21 PM 05/24/2024 7:07 PM
108-8242 03/15/2024 8:25 PM 05/24/2024 10:24 AM
04/08/2024 11:39 PM 05/24/2024 9:29 AM
170-8633 02/23/2024 3:20 AM 05/23/2024 4:52 AM
07034904 03/22/2024 6:19 PM 05/23/2024 2:11 AM
180-8750 03/04/2024 8:08 PM 05/22/2024 6:45 PM
05/09/2024 9:59 PM 05/22/2024 2:36 AM
06705030 05/21/2024 7:33 PM 05/21/2024 7:33 PM
92100 03/01/2024 8:58 PM 05/21/2024 6:48 PM
567-8680 04/23/2024 7:18 PM 05/21/2024 1:49 PM
21040-900 05/03/2024 11:55 PM 05/20/2024 9:38 PM
102-0075 05/05/2024 1:44 AM 05/20/2024 7:33 AM
28037 03/28/2024 1:13 AM 05/17/2024 4:24 PM
113-8650 03/03/2024 7:42 PM 05/17/2024 12:55 PM
61352 03/07/2024 12:17 AM 05/17/2024 12:27 PM
03/11/2024 9:28 PM 05/16/2024 7:58 PM
W1S 2HR 03/01/2024 9:43 PM 05/16/2024 3:28 PM
6340 05/09/2024 7:34 PM 05/16/2024 12:37 PM
04/18/2024 1:23 AM 05/16/2024 8:24 AM
DE14 2WW 04/15/2024 8:43 PM 05/15/2024 1:00 PM
104-8002 03/01/2024 10:34 PM 05/15/2024 10:02 AM
N6G 4X8 03/08/2024 2:19 AM 05/14/2024 10:49 PM
04582020 03/01/2024 8:04 PM 05/14/2024 7:45 PM
M5G1L7 04/04/2024 11:24 PM 05/14/2024 6:05 PM
100-0004 03/02/2024 1:08 AM 05/14/2024 1:42 PM
107-0052 04/29/2024 9:26 PM 05/14/2024 2:46 AM
103-0023 02/23/2024 1:08 AM 05/13/2024 8:00 PM
08970 03/04/2024 8:27 PM 05/13/2024 7:35 PM
100-0006 02/23/2024 1:20 AM 05/13/2024 6:54 PM
72076 03/01/2024 11:20 PM 05/13/2024 5:35 PM
160-8515 05/01/2024 6:51 PM 05/13/2024 12:25 PM
05/05/2024 4:08 PM 05/12/2024 4:16 PM
BA2 7AY 02/23/2024 1:09 AM 05/12/2024 12:05 AM
T2N 1N4 04/09/2024 1:31 AM 05/10/2024 10:56 PM
05676-120 05/03/2024 9:14 PM 05/10/2024 7:35 PM
08029 03/06/2024 10:20 PM 05/10/2024 7:00 PM
100-0005 03/01/2024 5:40 PM 05/10/2024 11:47 AM
61118 04/15/2024 11:00 PM 05/10/2024 2:22 AM
07034904 05/03/2024 9:32 PM 05/09/2024 8:09 PM
05/09/2024 4:55 PM 05/09/2024 4:55 PM
103-8351 03/04/2024 8:07 PM 05/09/2024 12:50 PM
03/25/2024 9:26 PM 05/08/2024 9:33 PM
04/19/2024 1:18 AM 05/08/2024 4:56 PM
04/30/2024 8:29 PM 05/08/2024 3:04 PM
HA1 4HF 02/21/2024 11:28 PM 05/08/2024 12:11 PM
03/07/2024 9:22 PM 05/07/2024 4:28 AM
04/25/2024 12:20 AM 05/07/2024 12:38 AM
05/03/2024 11:54 PM 05/06/2024 10:47 PM
113-8510 05/05/2024 4:18 PM 05/05/2024 4:18 PM
EC4Y 0AN 05/04/2024 2:04 AM 05/04/2024 4:55 AM
03/01/2024 10:35 PM 05/03/2024 4:00 PM
104-8315 02/27/2024 11:17 PM 05/03/2024 10:53 AM
03/01/2024 10:26 PM 05/03/2024 8:32 AM
13186-901 05/02/2024 8:06 PM 05/02/2024 8:06 PM
100-8585 03/07/2024 10:31 PM 05/02/2024 11:48 AM
DD1 5EH 04/16/2024 9:26 PM 05/01/2024 4:56 PM
03/08/2024 2:01 AM 05/01/2024 1:27 AM
05503-900 04/23/2024 11:51 PM 04/30/2024 11:53 PM
82194 03/05/2024 10:59 PM 04/30/2024 7:35 PM
100-6330 03/15/2024 1:45 AM 04/30/2024 3:28 PM
94250 03/06/2024 6:41 PM 04/30/2024 2:27 PM
103-6119 03/06/2024 6:53 PM 04/30/2024 2:15 PM
08022 03/06/2024 6:13 PM 04/30/2024 12:01 AM
05036040 04/09/2024 12:07 AM 04/29/2024 10:37 PM
K1A 0R6 04/26/2024 6:19 PM 04/26/2024 6:19 PM
105-0023 04/26/2024 1:47 AM 04/26/2024 1:47 AM
W1J 0AH 04/25/2024 6:52 PM 04/25/2024 6:52 PM
04/25/2024 6:17 PM 04/25/2024 6:17 PM
100-8585 04/16/2024 8:01 PM 04/25/2024 2:18 PM
20053 04/22/2024 7:47 PM 04/24/2024 1:41 PM
104-8356 04/23/2024 6:46 PM 04/24/2024 1:09 PM
100-8405 04/04/2024 8:21 PM 04/24/2024 12:10 PM
105-0023 03/01/2024 11:12 PM 04/24/2024 7:28 AM
04/22/2024 11:39 PM 04/23/2024 1:53 PM
103-8324 03/01/2024 12:50 AM 04/23/2024 9:27 AM
04/16/2024 9:59 PM 04/19/2024 7:04 PM
04538133 04/12/2024 7:04 PM 04/18/2024 10:28 PM
103-8433 03/02/2024 1:06 AM 04/18/2024 7:48 PM
02101 03/05/2024 6:29 PM 04/18/2024 1:39 PM
1000004 02/27/2024 11:36 PM 04/18/2024 10:18 AM
02/29/2024 9:10 PM 04/17/2024 6:48 PM
92160 04/16/2024 9:44 PM 04/16/2024 9:44 PM
63100 03/05/2024 6:09 PM 04/16/2024 8:50 PM
100-0004 03/29/2024 5:54 PM 04/16/2024 1:52 PM
EC3A 8BE 04/15/2024 8:47 PM 04/15/2024 8:47 PM
92150 03/25/2024 6:44 PM 04/12/2024 5:25 PM
04/04/2024 12:37 AM 04/10/2024 6:25 PM
108-0023 04/01/2024 3:44 PM 04/10/2024 6:22 AM
TW8 9GS 03/02/2024 12:05 AM 04/08/2024 7:31 PM
541-0048 02/23/2024 3:15 AM 04/05/2024 3:25 AM
02/28/2024 12:23 AM 04/04/2024 1:45 PM
20092 03/01/2024 8:52 PM 03/29/2024 12:02 AM
03/25/2024 9:53 PM 03/28/2024 8:41 PM
03/25/2024 9:46 PM 03/28/2024 2:52 PM
5310071 02/27/2024 6:30 PM 03/28/2024 8:00 AM
20148 02/29/2024 1:17 AM 03/27/2024 10:55 PM
772-8601 03/27/2024 9:04 PM 03/27/2024 9:04 PM
536-8523 03/01/2024 8:30 PM 03/27/2024 1:28 PM
08174 03/27/2024 1:11 AM 03/27/2024 1:11 AM
399-8710 03/02/2024 1:28 AM 03/26/2024 7:37 PM
L5K 2L3 02/29/2024 9:42 PM 03/26/2024 6:23 PM
1128088 03/01/2024 7:20 PM 03/26/2024 2:50 AM
F-69367 Lyon cedex 07 03/11/2024 9:46 PM 03/11/2024 9:46 PM
03/07/2024 9:22 PM 03/07/2024 9:22 PM
28033 03/07/2024 9:04 PM 03/07/2024 9:04 PM
08038 03/07/2024 8:30 PM 03/07/2024 8:30 PM
860-8568 03/05/2024 6:32 PM 03/05/2024 6:32 PM
755-8633 03/04/2024 8:12 PM 03/04/2024 8:12 PM
52078 03/02/2024 12:18 AM 03/02/2024 12:18 AM
08174 03/02/2024 12:17 AM 03/02/2024 12:17 AM
33500 03/01/2024 10:12 PM 03/01/2024 10:12 PM
92100 03/01/2024 8:48 PM 03/01/2024 8:48 PM
03/01/2024 8:34 PM 03/01/2024 8:34 PM
1162 03/01/2024 12:59 AM 03/01/2024 12:59 AM
E20 1JQ 02/29/2024 11:09 PM 02/29/2024 11:09 PM
530-8552 02/28/2024 2:28 AM 02/28/2024 2:28 AM
248-8555 02/28/2024 2:24 AM 02/28/2024 2:24 AM
02/27/2024 6:56 PM 02/27/2024 6:56 PM
06511 02/23/2024 12:26 AM 02/23/2024 12:26 AM
Company name Meeting status Company status Investor type Brief description
Description Objectives Investment stage preference Preferred company type(s)
Preferred asset type(s) Prefered therapeutic area(s)
Preferred asset development phase(s) Website Main email Main phone Country
State City Street address Postal code Created date/time Last updated date/time